Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Supports healthy metabolism and hormonal regulation
Merit Pharmaceutical makes no representations or warranties, express or implied, that the information contained on this website is accurate, current, complete, or reliable
It supports recovery across soft tissue, gut, and vascular systems, making it a cornerstone of modern peptide therapy
Luckily, BPC-157 has the potential to treat inflammation
How it works: GHRH receptor agonism (CJC-1295): binds pituitary somatotrophs via the GHRH receptor, amplifying baseline GH pulse amplitude and duration over the course of days due to albumin binding Ghrelin receptor agonism (Ipamorelin): activates GHS-R1a with an earlier onset and more immediate GH secretion spike compared to GHRH analogs, providing a complementary time profile Sequential synergy: the two peptides act on distinct receptor systems and exhibit a combined GH output greater than either alone, with ipamorelin providing the acute peak and CJC-1295 sustaining elevated trough levels IGF-1 elevation: downstream GH signaling raises circulating IGF-1, the primary mediator of tissue repair, protein synthesis, and connective tissue remodeling
US$ 29.01
US$ 23.92
US$ 27.26
US$ 29.37
